Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
519
archived clinical trials in
Bronchitis

Mesenchymal Stem Cell Therapy for Lung Rejection
A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate Lung Rejection
Status: Enrolling
Updated:  9/21/2015
mi
from
Jacksonville, FL
Mesenchymal Stem Cell Therapy for Lung Rejection
A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate Lung Rejection
Status: Enrolling
Updated: 9/21/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated:  9/29/2015
mi
from
Aurora, CO
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated: 9/29/2015
Children's Hospital and University Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated:  9/29/2015
mi
from
Columbus, OH
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated: 9/29/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated:  9/29/2015
mi
from
Birmingham, AL
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated: 9/29/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated:  9/29/2015
mi
from
Nashville, TN
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated: 9/29/2015
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated:  9/29/2015
mi
from
San Diego, CA
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated: 9/29/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated:  9/29/2015
mi
from
Chicago, IL
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Non-invasive Inhaled Nitric Oxide in Premature Newborns
Status: Enrolling
Updated: 9/29/2015
Anne and Robert H. Lurie Children's Hospital of Chicago and Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Phoenix, AZ
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
St. Joseph's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Loma Linda, CA
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Los Angeles, CA
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Univeristy of Southern California/Good Samaritan Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Denver, CO
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
The Children's Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Farmington, CT
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Iowa City, IA
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
University of Iowa Hospital and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Chapel Hill, NC
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Durham, NC
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Oklahoma City, OK
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Children's Hospital of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Philadelphia, PA
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Pittsburgh, PA
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Charleston, SC
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Nashville, TN
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated:  10/5/2015
mi
from
Provo, UT
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Inhaled NO for the Prevention of Chronic Lung Disease
Status: Enrolling
Updated: 10/5/2015
Utah Valley Regional Medical Center
mi
from
Provo, UT
Click here to add this to my saved trials
HFCWO in Hospitalized Asthmatic Children
High Frequency Chest Wall Oscillation in Hospital Management of Asthmatic Children
Status: Enrolling
Updated:  10/22/2015
mi
from
Long Island, NY
HFCWO in Hospitalized Asthmatic Children
High Frequency Chest Wall Oscillation in Hospital Management of Asthmatic Children
Status: Enrolling
Updated: 10/22/2015
Winthrop University Hospital, Winthrop Pediatric Associates
mi
from
Long Island, NY
Click here to add this to my saved trials
HFCWO in Hospitalized Asthmatic Children
High Frequency Chest Wall Oscillation in Hospital Management of Asthmatic Children
Status: Enrolling
Updated:  10/22/2015
mi
from
Long Island, NY
HFCWO in Hospitalized Asthmatic Children
High Frequency Chest Wall Oscillation in Hospital Management of Asthmatic Children
Status: Enrolling
Updated: 10/22/2015
Winthrop University Hospital
mi
from
Long Island, NY
Click here to add this to my saved trials
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II Study
Status: Enrolling
Updated:  11/4/2015
mi
from
Ann Arbor, MI
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II Study
Status: Enrolling
Updated: 11/4/2015
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Morgantown, WV
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Morgantown, WV
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Jasper, AL
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Mobile, AL
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Huntington Beach, CA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Los Angeles, CA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Clearwater, FL
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Ormond Beach, FL
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Lawrenceville, GA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Topeka, KA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Topeka, KA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Madisonville, KY
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Madisonville, KY
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Lafayette, LA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Lafayette, LA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
New Orleans, LA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
St. Louis, MO
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Charlotte, NC
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Elizabeth City, NC
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Elizabeth City, NC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Cincinnati, OH
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Medford, OR
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Beaver, PA
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Beaver, PA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Easley, SC
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Easley, SC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Spartanburg, SC
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  11/19/2015
mi
from
Ciudad Autonoma de Buenos Aires,
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 11/19/2015
GSK Investigational Site
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
A Double-Blind, Controlled, Randomized Clinical Trial of Nebulized Hypertonic Saline for Hospitalized Infants With Viral Bronchiolitis
Status: Enrolling
Updated:  11/20/2015
mi
from
Bronx, NY
A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
A Double-Blind, Controlled, Randomized Clinical Trial of Nebulized Hypertonic Saline for Hospitalized Infants With Viral Bronchiolitis
Status: Enrolling
Updated: 11/20/2015
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
mi
from
Stanford, CA
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
mi
from
Boston, MA
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
mi
from
Minneapolis, MN
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
mi
from
Buffalo, NY
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials